BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16837817)

  • 21. Renoprotective effects of asialoerythropoietin in diabetic mice against ischaemia-reperfusion-induced acute kidney injury.
    Nakazawa J; Isshiki K; Sugimoto T; Araki S; Kume S; Yokomaku Y; Chin-Kanasaki M; Sakaguchi M; Koya D; Haneda M; Kashiwagi A; Uzu T
    Nephrology (Carlton); 2010 Feb; 15(1):93-101. PubMed ID: 20377776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbamylated Erythropoietin Outperforms Erythropoietin in the Treatment of AKI-on-CKD and Other AKI Models.
    Tögel FE; Ahlstrom JD; Yang Y; Hu Z; Zhang P; Westenfelder C
    J Am Soc Nephrol; 2016 Nov; 27(11):3394-3404. PubMed ID: 26984884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.
    Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat.
    Bagnis C; Beaufils H; Jacquiaud C; Adabra Y; Jouanneau C; Le Nahour G; Jaudon MC; Bourbouze R; Jacobs C; Deray G
    Nephrol Dial Transplant; 2001 May; 16(5):932-8. PubMed ID: 11328897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietin enhances recovery from cisplatin-induced acute renal failure.
    Vaziri ND; Zhou XJ; Liao SY
    Am J Physiol; 1994 Mar; 266(3 Pt 2):F360-6. PubMed ID: 8160783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel renoprotective actions of erythropoietin: new uses for an old hormone.
    Johnson DW; Forman C; Vesey DA
    Nephrology (Carlton); 2006 Aug; 11(4):306-12. PubMed ID: 16889570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renoprotective effect of erythropoietin against ischaemia-reperfusion injury in a non-human primate model.
    Ishii Y; Sawada T; Murakami T; Sakuraoka Y; Shiraki T; Shimizu A; Kubota K; Fuchinoue S; Teraoka S
    Nephrol Dial Transplant; 2011 Apr; 26(4):1157-62. PubMed ID: 20935018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise.
    Brines M; Cerami A
    Kidney Int; 2006 Jul; 70(2):246-50. PubMed ID: 16738535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of erythropoietin on renal injury induced by acute exhaustive exercise in the rat.
    Lin X; Qu S; Hu M; Jiang C
    Int J Sports Med; 2010 Dec; 31(12):847-53. PubMed ID: 21072740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renoprotection and Mechanisms of Erythropoietin and Its Derivatives Helix B Surface Peptide in Kidney Injuries.
    Zhang Y; Chen W; Wu Y; Yang B
    Curr Protein Pept Sci; 2017; 18(12):1183-1190. PubMed ID: 27634442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythropoietin-enhanced endothelial progenitor cell recruitment in peripheral blood and renal vessels during experimental acute kidney injury in rats.
    Cakiroglu F; Enders-Comberg SM; Pagel H; Rohwedel J; Lehnert H; Kramer J
    Cell Biol Int; 2016 Mar; 40(3):298-307. PubMed ID: 26616141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic and renal haemodynamic changes in renal schemia/reperfusion injury: impact of erythropoietin.
    Hussein AA; Barakat N; Awadalla A; Shokeir AA
    Can J Physiol Pharmacol; 2012 Nov; 90(11):1535-43. PubMed ID: 23181281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human erythropoietin attenuates renal tubulointerstitial injury in murine adriamycin-induced nephropathy.
    Nakazawa Y; Nishino T; Obata Y; Nakazawa M; Furusu A; Abe K; Miyazaki M; Koji T; Kohno S
    J Nephrol; 2013; 26(3):527-33. PubMed ID: 22684648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin expands a stromal cell population that can mediate renoprotection.
    Bi B; Guo J; Marlier A; Lin SR; Cantley LG
    Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1017-22. PubMed ID: 18653480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of erythropoietin in prevention of amikacin-induced nephropathy.
    Kaynar K; Aliyazioglu R; Ersoz S; Ulusoy S; Al S; Ozkan G; Cansiz M
    J Nephrol; 2012; 25(5):744-9. PubMed ID: 22322815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin attenuates renal ischemia and reperfusion injury-induced restrictive respiratory insufficiency.
    Yeh JH; Yang YC; Wang JC; Wang D; Wang JJ
    Transplant Proc; 2013; 45(10):3542-5. PubMed ID: 24314954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unexpected renal actions of erythropoietin.
    Westenfelder C
    Exp Nephrol; 2002; 10(5-6):294-8. PubMed ID: 12381912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment.
    Wang Z; Schley G; Türkoglu G; Burzlaff N; Amann KU; Willam C; Eckardt KU; Bernhardt WM
    Nephrol Dial Transplant; 2012 Mar; 27(3):929-36. PubMed ID: 21742784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury.
    van der Meer P; Lipsic E; Henning RH; de Boer RA; Suurmeijer AJ; van Veldhuisen DJ; van Gilst WH
    Eur J Heart Fail; 2004 Dec; 6(7):853-9. PubMed ID: 15556046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental models of acute renal failure and erythropoietin: what evidence of a direct effect?
    Sturiale A; Campo S; Crascì E; Aloisi C; Buemi M
    Ren Fail; 2007; 29(3):379-86. PubMed ID: 17497457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.